Skip to main content
Clinical Trials/JPRN-UMIN000052115
JPRN-UMIN000052115
Not yet recruiting
未知

An efficay test for the cosmetic product containing stable neutral vitamin C derivative for 24 weeks on people with senile pigment spots. - An efficay test for the cosmetic product containing stable neutral vitamin C derivative for 24 weeks on people with senile pigment spots.

Inforward, inc.0 sites25 target enrollmentSeptember 14, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Healty volunteers
Sponsor
Inforward, inc.
Enrollment
25
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 14, 2023
End Date
March 15, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Inforward, inc.

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.People with severe hay fever. 2\.Those who are being treated for chronic skin diseases such as atopic dermatitis. 3\.Subjects who are likely to expose the test site to sunlight during the test period.(Daily outdoor sports, etc.) 4\.Those who have taken medicines containing tranexamic acid, vitamin C, or L\-cysteine for skin whitening within 2 months before the start of the study. 5\.Persons who have had allergic symptoms to cosmetics, etc. in the past. 6\.People who regularly drink large amounts of alcohol. 7\.Those who have a history of serious gastrointestinal disorder, liver disorder, renal disorder, myocardial infarction, mental illness, etc. 8\.Persons with severe anemia. 9\.Those who are currently pregnant, breastfeeding, or wish to become pregnant during the study period. 10\.Those who have a family member working for a pharmaceutical manufacturer or cosmetics company. 11\.Those who are currently participating in clinical trials, usage surveys, and product monitors for cosmetic products, pharmaceuticals, etc., or those who have participated within the last three months. 12\.Subjects who are otherwise ineligible for participation in this study by the investigater.

Outcomes

Primary Outcomes

Not specified

Similar Trials